Drug intelligence / Profile preview

fluocinolone acetonide topical oil

Development stage
Approved
Lead developer
Hill Dermaceuticals
Modality
Small Molecules
Administration
Topical
01

Overview

Fluocinolone acetonide topical oil is a low-to-medium potency corticosteroid formulation containing 0.01% fluocinolone acetonide. It is a synthetic fluorinated corticosteroid with anti-inflammatory, antipruritic, and vasoconstrictive properties. The oil formulation is specifically indicated for the treatment of inflammatory skin conditions, including atopic dermatitis in pediatric and adult patients, and seborrheic dermatitis of the scalp. As a synthetic glucocorticoid, it diffuses across cell membranes to bind with high affinity to cytoplasmic glucocorticoid receptors. This complex then translocates to the nucleus, where it modulates gene expression to induce the production of anti-inflammatory proteins (such as lipocortins) and inhibit the synthesis of pro-inflammatory mediators like prostaglandins and leukotrienes. The oil vehicle is particularly effective for treating hairy areas like the scalp or for providing an occlusive effect on dry, eczematous skin.

Brand names
Derma-Smoothe/FS
Other names
fluocinolone acetonidefluocinolone acetonide 0.01% topical oil
02

Targets

GR (Glucocorticoid receptor)

Beyond the preview

Go deeper on fluocinolone acetonide topical oil.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on fluocinolone acetonide topical oil.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call